These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2879317)

  • 1. CSF neurotransmitter markers in Alzheimer's disease.
    Beal MF; Growdon JH
    Prog Neuropsychopharmacol Biol Psychiatry; 1986; 10(3-5):259-70. PubMed ID: 2879317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrospinal fluid vasopressin, oxytocin, somatostatin, and beta-endorphin in Alzheimer's disease.
    Raskind MA; Peskind ER; Lampe TH; Risse SC; Taborsky GJ; Dorsa D
    Arch Gen Psychiatry; 1986 Apr; 43(4):382-8. PubMed ID: 2869744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A correlation study of CSF neuropeptides in Alzheimer's and Parkinson's disease.
    Jolkkonen J; Hartikainen P; Soikkeli R; Bissette G; Nemeroff C; Riekkinen P
    Neuropeptides; 1991 Jun; 19(2):97-102. PubMed ID: 1682848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurochemical markers in the cerebrospinal fluid of patients with Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis and normal controls.
    Hartikainen P; Reinikainen KJ; Soininen H; Sirviö J; Soikkeli R; Riekkinen PJ
    J Neural Transm Park Dis Dement Sect; 1992; 4(1):53-68. PubMed ID: 1347220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioral correlates of cerebrospinal fluid amino acid and biogenic amine neurotransmitter alterations in dementia.
    Vermeiren Y; Le Bastard N; Van Hemelrijck A; Drinkenburg WH; Engelborghs S; De Deyn PP
    Alzheimers Dement; 2013 Sep; 9(5):488-98. PubMed ID: 23159046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CSF monoamine metabolites, cholinesterases and lactate in the adult hydrocephalus syndrome (normal pressure hydrocephalus) related to CSF hydrodynamic parameters.
    Malm J; Kristensen B; Ekstedt J; Adolfsson R; Wester P
    J Neurol Neurosurg Psychiatry; 1991 Mar; 54(3):252-9. PubMed ID: 1709421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ventricular cerebrospinal fluid monoamine transmitter and metabolite concentrations reflect human brain neurochemistry in autopsy cases.
    Wester P; Bergström U; Eriksson A; Gezelius C; Hardy J; Winblad B
    J Neurochem; 1990 Apr; 54(4):1148-56. PubMed ID: 1968956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal fluid concentrations of somatostatin and biogenic amines in grown primates reared by mothers exposed to manipulated foraging conditions.
    Coplan JD; Trost RC; Owens MJ; Cooper TB; Gorman JM; Nemeroff CB; Rosenblum LA
    Arch Gen Psychiatry; 1998 May; 55(5):473-7. PubMed ID: 9596051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrospinal fluid neuropeptides in Alzheimer's disease and vascular dementia.
    Heilig M; Sjögren M; Blennow K; Ekman R; Wallin A
    Biol Psychiatry; 1995 Aug; 38(4):210-6. PubMed ID: 8547442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CSF monoamine metabolites and somatostatin in Alzheimer's disease and major depression.
    Molchan SE; Lawlor BA; Hill JL; Martinez RA; Davis CL; Mellow AM; Rubinow DR; Sunderland T
    Biol Psychiatry; 1991 Jun; 29(11):1110-8. PubMed ID: 1714776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Metabolic and Synaptic Dysfunction Hypotheses of Alzheimer's Disease (AD): A Meta-Analysis of CSF Markers.
    Manyevitch R; Protas M; Scarpiello S; Deliso M; Bass B; Nanajian A; Chang M; Thompson SM; Khoury N; Gonnella R; Trotz M; Moore DB; Harms E; Perry G; Clunes L; Ortiz A; Friedrich JO; Murray IVJ
    Curr Alzheimer Res; 2018; 15(2):164-181. PubMed ID: 28933272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seasonal variations of human lumbar CSF neurotransmitter metabolite concentrations.
    Losonczy MF; Mohs RC; Davis KL
    Psychiatry Res; 1984 May; 12(1):79-87. PubMed ID: 6205414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurotransmitter measures in the cerebrospinal fluid of patients with Alzheimer's disease: a review.
    Strac DS; Muck-Seler D; Pivac N
    Psychiatr Danub; 2015 Mar; 27(1):14-24. PubMed ID: 25751428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurotransmitter changes in Alzheimer's disease: implications to diagnostics and therapy.
    Reinikainen KJ; Soininen H; Riekkinen PJ
    J Neurosci Res; 1990 Dec; 27(4):576-86. PubMed ID: 1981917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurochemical differences in the CSF between Binswanger's and Alzheimer's disease.
    Strittmatter M; Hamann GF; Grauer MT; Cramer H; Schimrigk K
    Dement Geriatr Cogn Disord; 1997; 8(1):34-42. PubMed ID: 8997550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acetylcholinesterase activities and monoamine metabolite levels in the cerebrospinal fluid of patients with Alzheimer's disease.
    Kawakatsu S; Morinobu S; Shinohara M; Totsuka S; Kobashi K
    Biol Psychiatry; 1990 Sep; 28(5):387-400. PubMed ID: 1698467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gamma-aminobutyric acid and homovanillic acid concentration in the CSF of patients with senile dementia of Alzheimer's type.
    Zimmer R; Teelken AW; Trieling WB; Weber W; Weihmayr T; Lauter H
    Arch Neurol; 1984 Jun; 41(6):602-4. PubMed ID: 6721733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CSF neuropeptides in euthymic bipolar patients and controls.
    Berrettini WH; Nurnberger JI; Zerbe RL; Gold PW; Chrousos GP; Tomai T
    Br J Psychiatry; 1987 Feb; 150():208-12. PubMed ID: 2888503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of decreased lumbar CSF levels of HVA and 5-HIAA in Alzheimer's disease.
    Blennow K; Wallin A; Gottfries CG; Lekman A; Karlsson I; Skoog I; Svennerholm L
    Neurobiol Aging; 1992; 13(1):107-13. PubMed ID: 1371850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CSF tau, Aβ42, and MHPG differentiate dementia with Lewy bodies from Alzheimer's disease.
    Aerts MB; Esselink RA; Claassen JA; Abdo WF; Bloem BR; Verbeek MM
    J Alzheimers Dis; 2011; 27(2):377-84. PubMed ID: 21841257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.